Subfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degeneration AMD

1 clinical trials · Condition

Record	Firm	Date
Comparison of Treatment Regimens Using Ranibizumab: Intensive (Resolution of Intra- and Sub-retinal Fluid) vs Relaxed (Resolution of Intra-retinal Fluid and/or Sub-retinal Fluid >200µm at the Foveal Centre) (NCT01972789)	Novartis Pharmaceuticals	2013-10-31

Every clearance here is in the API, with alerts when new ones post.